Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFILA 100 mg delayed-release tablets.
http://www.businesswire.com/news/topix/20131126005654/en
http://www.businesswire.com/news/topix/20131126005654/en
No comments:
Post a Comment